1. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

   • Katsutoshi Tokushige
   • Kenichi Ikejima
   • Kazuhiko Koike

   Review Article Open access 17 September 2021 Pages: 951 - 963

   

2. A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database

   • Vincent Quoc-Huy Trinh
   • Nooshin Karamzadeh Dashti
   • Justin Merrill Marken Cates

   Original Article—Alimentary Tract 25 September 2021 Pages: 964 - 975

   

3. Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease

   • Kei Nishioka
   • Haruei Ogino
   • Yoshihiro Ogawa

   Original Article—Alimentary Tract 27 August 2021 Pages: 976 - 987

   

4. APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum

   • Kenichi Ishizu
   • Taiki Hashimoto
   • Shigeki Sekine

   Original Article—Alimentary Tract 12 September 2021 Pages: 988 - 998

   

5. Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation

   • Takahiko Toyonaga
   • Taku Kobayashi
   • Toshifumi Hibi

   Original Article—Alimentary Tract 04 September 2021 Pages: 999 - 1007

   

6. Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs

   • Daiki Yamashige
   • Tetsuya Hosaka
   • Hiromitsu Kumada

   Original Article—Liver, Pancreas, and Biliary Tract 01 October 2021 Pages: 1008 - 1021

   

7. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

   • Masato Yoneda
   • Takuma Yamamoto
   • Atsushi Nakajima

   Original Article—Liver, Pancreas, and Biliary Tract Open access 03 October 2021 Pages: 1022 - 1032

   

8. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

   • Tetsuhide Ito
   • Toshihiko Masui
   • Shinji Uemoto

   Original Article—Liver, Pancreas, and Biliary Tract Open access 29 September 2021 Pages: 1033 - 1044